| Role |
Name |
Disclosure |
Details |
| Author | Cameron K Tebbi, MD, Medical Director, Department of Pediatric Hematology-Oncology, Tampa Children's Hospital | Nothing to disclose | Details | | Coauthor | Robert J Arceci, MD, PhD, King Fahd Professor of Pediatric Oncology, Department of Oncology, Division of Pediatric Oncology, Johns Hopkins University School of Medicine | Nothing to disclose | Details | | Coauthor | Thomas W Loew, MD, Clinical Professor of Pediatrics, Director of Pediatric Hematology/Oncology Subspecialty Training Program, University of Iowa Hospitals and Clinics | Genzyme Genzyme Amicus Purdue Pharmaceuticals | Details | | Medical Editor | Gary R Jones, MD, Associate Medical Director, Clinical Development, Berlex Laboratories | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Gary D Crouch, MD, Program Director of Pediatric Hematology-Oncology Fellowship, Department of Pediatrics, Associate Professor, Uniformed Services University of the Health Sciences | Nothing to disclose | Details | | CME Editor | Helen SL Chan, MBBS, FRCP(C), FAAP, Senior Scientist, Research Institute; Professor, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Canada | Nothing to disclose | Details | | Chief Editor | Max J Coppes, MD, PhD, MBA, Executive Director, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Professor of Medicine, Oncology, and Pediatrics, Georgetown University | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Gary R Jones, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Gary D Crouch, Managing Editor |
The contributor discloses no conflict of interest. |
|